Global Next-Generation Sequencing (NGS) Market 2018-2024
  • ID: 1250
  • June 14, 2018
  • 103 pages
  • Infoholic Research

Global Next-generation sequencing Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Next-generation sequencing (NGS) is the massively parallel sequencing technology that has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible. Illumina, Pacific Biosciences of California, Thermo Fisher scientific and Oxford Nanopore technology offers next-generation sequencing instruments based on different technologies such as Reversible terminator sequencing, Sequencing by ligation, Single-molecule, real-time sequencing (SMRT), ion semiconductor sequencing technology and Nanopore sequencing technology respectively. Wide range of diagnostic applications, continuous technology advancements are making it more efficient and user-friendly, but the complications associated with data storage and lack of skilled professional are some of the factors which may hamper growth to an extent.
Market Analysis: The “Global Next-Generation Sequencing market” is estimated to witness a CAGR of 18.6% during the forecast period 2018–2024. The global market is analyzed based on five segments – Technology, Products, Application, End-users and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global next-generation sequencing market, followed by Europe. Asia-Pacific region is expected to grow at high CAGR during the forecasted period due to increasing funding for healthcare research, growing patient pool, and increasing healthcare expenditure. The markets in emerging counties such as, India, China and Brazil are expected to grow at a rapid pace for next five years.
Technology Analysis: The next-generation sequencing market by technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real-time sequencing, nanopore sequencing and others. Reversible terminator sequencing occupied a major market share in 2017 and is expected to remain same during the forecasted period.
Product Analysis: The market by product type is segmented into instruments, consumables and reagents and services. The services segment of the NGS market includes data analysis services and sequencing services. Among various application, consumables and reagents occupied the largest share in 2017, due to increased usage and need of consumables throughout the sample preparation, library construction, and various other pre-requisite steps of next-generation sequencing.
Application Analysis: The market by application is segmented into diagnostics, biomarker discovery, drug discovery, agriculture and animal research and others. Diagnostics includes prenatal testing, cancer diagnostics, genetic screening, pre-implantation, HLA typing and various other clinical diagnostics applications. The diagnostics application occupied a major share in 2017, due to increasing usage of next-generation sequencing for disease diagnosis.
End-Users Analysis: The market by end-users is segmented into academic and research institutes, hospitals and clinics, biotech and pharma companies and others. Among various end-users of the NGS market, academic and research institutes occupied a major share in 2017.
Key Players: Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players.
Competitive Analysis: Currently the next-generation sequencing market is consolidated with few key companies due to the involvement of complicated technologies and the requirement of high capital investment. Sequencing based test may soon be regarded as the gold standard in the field of molecular diagnostics. The increase in the applications of NGS has made many biotechnological firms and diagnostic laboratories to invest heavily in this field by launching new products or acquiring other smaller firms or by collaboration. For instance, in August 2017, US based Illumina and Telegraph Hill Partners launched Verogen, Inc. to drive adoption of NGS in the global forensic genomics Market. In February 2018, Twist Bioscience entered the NGS sample prep market with the launch of its first target enrichment products. In March 2017, MedGenome launched NGS based liquid biopsy blood test “Oncotrack” for the diagnosis of cancer in India.
Benefits: The report provides complete details about the usage and adoption rate of Next-generation Sequencing in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents
1 Industry Outlook 8
1.1 Market Overview 8
1.2 Total addressable market 8
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition – Infoholic Research 13
3.2 Advantages of next-generation sequencing 13
3.3 Segmented Addressable Market (SAM) 13
3.4 Trends of the next-generation sequencing market 13
3.5 Related Markets 14
3.5.1 Polymerase chain reaction (PCR) 14
3.5.2 In-situ Hybridization 15
3.5.3 Microarray 15
4 Market Outlook 16
4.1 Market segmentation 16
4.2 PEST Analysis 16
4.3 Porter 5(Five) Forces 17
5 Market Characteristics 19
5.1 DRO – Global Next-generation sequencing Market Dynamics 19
5.1.1 Drivers 19
5.1.1.1 Usage of sequencing in wide range of diagnostic application 19
5.1.1.2 High speed, accuracy and reduced sequencing cost 20
5.1.2 Opportunities 21
5.1.2.1 Emerging applications of next-generation sequencing 21
5.1.2.2 Evolution of personalized medicine 21
5.1.3 Restraints 22
5.1.3.1 Complications associated with NGS data storage 22
5.1.3.2 Lack of skilled professional 22
5.2 DRO – Impact Analysis 23
5.3 Key Stakeholders 23
6 Technology: Market Size & Analysis 25
6.1 Overview 25
6.2 Reversible terminator sequencing 26
6.3 Ion semiconductor sequencing 27
6.4 Sequencing by ligation 27
6.5 Single molecule real-time (SMRT) sequencing 28
6.6 Nanopore sequencing 28
6.7 Others 29
7 Product: Market Size & Analysis 31
7.1 Overview 31
7.2 Instruments 32
7.3 Consumables and reagents 32
7.4 Services 32
8 Applications: Market Size & Analysis 34
8.1 Overview 34
8.2 Diagnostics 36
8.3 Biomarker discovery 37
8.4 Drug discovery 38
8.5 Agriculture and animal research 39
8.6 Other application 40
9 End-User: Market Size & Analysis 42
9.1 Overview 42
9.2 Hospital and reference laboratories 43
9.3 Academic and research institutions 43
9.4 Biotech and pharma companies 43
9.5 Others 44
10 Regions: Market Size and Analysis 45
10.1 Overview 45
10.2 North America 46
10.3 Europe 47
10.4 Asia Pacific 48
10.5 Rest of the World 50
11 Competitive Landscape 51
11.1 Overview 51
12 Vendor Profiles 54
12.1 Illumina, Inc. 54
12.1.1 Overview 54
12.1.2 Illumina, Inc.: Recent Developments 57
12.1.3 Business Units 62
12.1.4 Geographic Revenue 63
12.1.5 Business Focus 64
12.1.6 SWOT Analysis 64
12.1.7 Business Strategies 65
12.2 Thermo Fisher Scientific Inc. 65
12.2.1 Overview 65
12.2.2 Thermo Fisher Scientific Inc.: Recent Developments 66
12.2.3 Business Units 70
12.2.4 Geographic Presence 71
12.2.5 Business Focus 71
12.2.6 SWOT Analysis 72
12.2.7 Business Strategies 72
12.3 Pacific Biosciences of California, Inc. 73
12.3.1 Overview 73
12.3.2 Geographic Presence 76
12.3.3 Business Focus 76
12.3.4 SWOT Analysis 76
12.3.5 Business Strategies 77
12.4 Oxford Nanopore Technologies Ltd 78
12.4.1 Overview 78
12.4.2 Business Focus 79
12.4.3 SWOT Analysis 79
12.4.4 Business Strategies 80
12.5 Beijing Genomics Institute 81
12.5.1 Overview 81
12.5.2 Business Focus 82
12.5.3 SWOT Analysis 83
12.5.4 Business Strategies 83
13 Companies to Watch for 85
13.1 DNASTAR, Inc., 85
13.1.1 Overview 85
13.2 Agilent Technologies, Inc. 86
13.2.1 Overview 86
13.3 Qiagen N.V. 91
13.3.1 Overview 91
13.4 Eurofins Scientific 95
13.4.1 Overview 95
13.5 Biomatters Limited 98
13.5.1 Overview 98
13.6 F. Hoffmann-La Roche 99
13.6.1 Overview 99
Annexure 102
 Acronyms 102

Table of Contents

TABLE 1 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY APPLICATION, 2017–2024 ($MILLION) 34
TABLE 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 45
TABLE 3 OTHER PROMINENT VENDORS OF NEXT-GENERATION SEQUENCING MARKET 53
TABLE 4 ILLUMINA, INC.: OFFERINGS 54
TABLE 5 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 66
TABLE 6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: OFFERINGS 73
TABLE 7 PACIFIC BIOSCIENCES OF CALIFORNIA, INC: RECENT DEVELOPMENTS 74
TABLE 8 OXFORD NANOPORE TECHNOLOGIES LTD: OFFERINGS 78
TABLE 9 OXFORD NANOPORE TECHNOLOGIES LTD: RECENT DEVELOPMENTS 78
TABLE 10 BEIJING GENOMICS INSTITUTE: OFFERINGS 81
TABLE 11 BEIJING GENOMICS INSTITUTE: RECENT DEVELOPMENTS 82
TABLE 12 DNASTAR, INC.: SNAPSHOT 85
TABLE 13 DNASTAR, INC.: RECENT DEVELOPMENTS 86
TABLE 14 AGILENT TECHNOLOGIES, INC.: SNAPSHOT 87
TABLE 15 AGILENT TECHNOLOGIES, INC.: RECENT DEVELOPMENTS 88
TABLE 16 QIAGEN N.V.: SNAPSHOT 91
TABLE 17 QIAGEN N.V.: RECENT DEVELOPMENTS 92
TABLE 18 EUROFINS SCIENTIFIC: SNAPSHOT 95
TABLE 19 EUROFIN SCIENTIFIC: RECENT DEVELOPMENTS 96
TABLE 20 BIOMATTERS LIMITED: SNAPSHOT 98
TABLE 21 BIOMATTERS LTD: RECENT DEVELOPMENTS 99
TABLE 22 F. HOFFMANN-LA ROCHE: SNAPSHOT 99
TABLE 23 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 100

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL NEXT-GENERATION SEQUENCING MARKET 11
CHART 2 GLOBAL NEXT-GENERATION SEQUENCING MARKET REVENUE, 2017–2024 ($MILLION) 14
CHART 3 SEGMENTATION OF GLOBAL NEXT-GENERATION SEQUENCING MARKET 16
CHART 4 PEST ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET 16
CHART 5 PORTER 5 FORCES ON GLOBAL NEXT-GENERATION SEQUENCING MARKET 17
CHART 6 DRO – IMPACT ANALYSIS OF GLOBAL NEXT-GENERATION SEQUENCING MARKET 23
CHART 7 KEY STAKEHOLDERS 23
CHART 8 GLOBAL NEXT-GENERATION SEQUENCING BY TECHNOLOGY SEGMENTATION, 2017 (%) 25
CHART 9 GLOBAL NEXT-GENERATION SEQUENCING BY PRODUCT SEGMENTATION, 2017 (%) 31
CHART 10 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2017 (%) 35
CHART 11 GLOBAL NEXT-GENERATION MARKET BY APPLICATION SEGMENTATION, 2024 (%) 35
CHART 12 GLOBAL DIAGNOSTICS MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 36
CHART 13 GLOBAL BIOMARKER DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 37
CHART 14 GLOBAL DRUG DISCOVERY MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 38
CHART 15 GLOBAL AGRICULTURE AND ANIMAL RESEARCH MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 39
CHART 16 GLOBAL OTHERS MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 40
CHART 17 GLOBAL NEXT-GENERATION SEQUENCING BY END-USERS SEGMENTATION, 2017 (%) 42
CHART 18 GLOBAL NEXT-GENERATION SEQUENCING MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 45
CHART 19 NEXT-GENERATION SEQUENCING MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 46
CHART 20 NEXT-GENERATION SEQUENCING MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION) 48
CHART 21 NEXT-GENERATION SEQUENCING MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION) 49
CHART 22 NEXT-GENERATION SEQUENCING MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION) 50
CHART 23 ILLUMINA, INC.: OVERVIEW SNAPSHOT 62
CHART 24 ILLUMINA, INC.: BUSINESS UNITS 62
CHART 25 ILLUMINA, INC.: GEOGRAPHIC REVENUE 63
CHART 26 ILLUMINA, INC.: SWOT ANALYSIS 64
CHART 27 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 69
CHART 28 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE 70
CHART 29 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE 71
CHART 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 72
CHART 31 PACIFIC BIOSIENCES OF CALIFORNIA, INC.: OVERVIEW SNAPSHOT 75
CHART 32 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: GEOGRAPHIC PRESENCE 76
CHART 33 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SWOT ANALYSIS 76
CHART 34 OXFORD NANOPORE TECHNOLOGIES LTD: SWOT ANALYSIS 79
CHART 35 BEIJING GENOMICS INSTITUTE: SWOT ANALYSIS 83

None

Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team